Divi’s Laboratories (DIVISLAB) Share Price Falls 2.04% as Large-Cap Pharma Stock Trades Lower
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Divi’s Laboratories Share Price is trading at Rs 9,282 after a 2.04% decline, with the company’s market capitalisation at Rs 2,53,031.38 Cr. The move matters because Divi’s Laboratories Share Price is falling from a previous close of Rs 9,475, even as the business remains a Large Cap in the Healthcare sector. According to latest Univest figures, the stock opened at Rs 9,475.30 and moved between Rs 9,503.15 and Rs 9,268.65 during the session, placing Divi’s Laboratories Share Price near the lower end of the range. For readers tracking Divi’s Laboratories Share Price Today, the first question is not only what changed in price, but how valuation, sector comparison and peer multiples frame the stock’s latest move.
From a market-news perspective, Divi’s Laboratories Share Price is drawing attention because the decline is taking place alongside rich valuation metrics and a premium market-cap profile within healthcare.That makes Divi’s Laboratories Share Price a useful case for stock analysis, fundamental analysis and sector analysis rather than a simple one-line move.
Divi's Laboratories (DIVISLAB) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 9,282 |
| Previous Close | Rs 9,475 |
| Today's Move | -Rs 193.00 (-2.04%) |
| Open | Rs 9,475.3 |
| High | Rs 9,503.15 |
| Low | Rs 9,268.65 |
| Market Capitalisation | Rs 2,53,031.38 crore |
| Market Cap Category | Large Cap |
Divi’s Laboratories Share Price Today reflects a Rs 193 fall from the previous close of Rs 9,475 to Rs 9,282, or -2.04%. The stock opened at Rs 9,475.30, touched a high of Rs 9,503.15 and a low of Rs 9,268.65, so the current level is close to the day’s low. With a market capitalisation of Rs 2,53,031.38 Cr, Divi’s Laboratories Share Price sits firmly in the Large Cap category. In practical terms, the move shows a lower intraday placement after starting around the prior close, and Divi’s Laboratories Share Price Today is now below the opening mark as well as below the previous close. For readers following Divi’s Laboratories Share Price Live, the day’s range offers the clearest picture of price action before moving into fundamental analysis.
Why Divi’s Laboratories (DIVISLAB) May Be Moving Today
Divi's Laboratories (DIVISLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,53,031.38 crore |
| P/E Ratio | 85.99x |
| P/B Ratio | 14.24x |
| ROE | 16.19% |
| ROCE | 21.51% |
| EPS | Rs 110.18 |
| Book Value Per Share | Rs 665.36 |
| Dividend Yield | 0.32% |
For investors tracking Divi’s Laboratories Financial Results and Divi’s Laboratories Earnings context, the key point is that Divi’s Laboratories Share Price embeds a premium on both earnings and book value. That does not tell readers to buy or sell; it simply shows why Divi’s Laboratories Share Price remains highly sensitive to any change in market sentiment, earnings trajectory or sector comparison. Univest tracks these numbers because they often matter more than a one-day move when Divi’s Laboratories Share Price is already priced above many peers.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 85.99x |
| Benchmark Median P/E | 32.43x |
| Benchmark Average P/E | 49.46x |
| Benchmark P/E Range | 3.4x to 699.02x |
| Company P/B Ratio | 14.24x |
| Benchmark Median P/B | 2.89x |
| Benchmark Average P/B | 4.38x |
| Company ROE | 16.19% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 21.51% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 2,53,031.38 crore |
| Benchmark Median Market Cap | Rs 776.09 crore |
| Benchmark Average Market Cap | Rs 14,255.4 crore |
Divi’s Laboratories Share Price can be understood better against the Healthcare sector and the Pharmaceuticals & Drugs industry, where valuation dispersion is wide. The benchmark scope covers the same industry and includes 199 companies. Within that set, the company P/E of 85.99 is well above the industry median of 32.43 and the industry average of 49.46. The company P/B of 14.24 also sits above the sector median of 2.89 and above the sector average of 4.38. ROE at 16.19% is above the industry median of 11.7% and the average of 10.68%, while ROCE at 21.51% is above the industry median of 13.61% and the average of 13.4%. In market-cap terms, Divi’s Laboratories Share Price belongs to a company far above the industry median market capitalisation of Rs 776.09 Cr. These numbers show that Divi’s Laboratories Share Price is positioned as a premium-valued large company within Healthcare.
That premium is visible in the broader sector comparison too. Divi’s Laboratories Share Price is priced above the centre of the industry range on earnings and book multiples, while its return ratios remain stronger than the sector midpoint. In Univest terms, this is a stock where valuation and operating returns need to be read together, not separately. For Divi’s Laboratories Stock News watchers, the sector context says the move is not simply about the day’s decline; it also reflects a stock already trading at a high multiple relative to the industry benchmark.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,41,477.63 | 36.9 | 5.16 | 14.85 | 19.11 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,85,216.32 | 85.72 | 20.83 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,20,897.46 | 26.42 | 4.42 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,205.15 | 33.15 | 3.18 | 11.83 | 16 |
| Laurus Labs | LAURUSLABS | 1,08,710.82 | 98.12 | 19.03 | 18.31 | 18.2 |
Divi’s Laboratories Share Price sits among a set of listed pharma peers where valuation gaps are meaningful. Against Sun Pharmaceutical Industries at a P/E of 36.9 and P/B of 5.16, Divi’s Laboratories Share Price looks materially richer on both measures. Against Torrent Pharmaceuticals, whose P/E is 85.72 and P/B is 20.83, Divi’s Laboratories Share Price is close on earnings valuation but lower on book value. Zydus Lifesciences trades at a P/E of 26.42 and P/B of 4.42, which places Divi’s Laboratories Share Price at a clear premium. Cipla at 33.15 times earnings and Dr. Reddy’s Laboratories at 32.38 times earnings also sit well below Divi’s Laboratories Share Price on P/E.
On return ratios, Divi’s Laboratories Share Price shows ROE of 16.19% and ROCE of 21.51%, which are stronger than Sun Pharma and Cipla, but below Torrent’s ROE and below Lupin’s listed return ratios in the broader peer set. Market-cap-wise, Divi’s Laboratories Share Price is larger than several peers in this comparison, though still below Sun Pharma and Torrent. That mix explains why Divi’s Laboratories Share Price attracts attention in peer comparison: the stock combines high valuation with respectable returns.
Why Investors Are Watching Divi’s Laboratories
- Divi’s Laboratories Share Price is down 2.04% today, so short-term price action is the first thing readers are tracking.
- The Large Cap status keeps Divi’s Laboratories Share Price important within Healthcare and the pharmaceuticals basket.
- Divi’s Laboratories Share Price trades on a high P/E and P/B, which keeps valuation central to any stock analysis.
- ROE of 16.19% and ROCE of 21.51% give Divi’s Laboratories Share Price return ratios worth comparing with peers.
- The latest Univest figures show a premium-priced company whose Divi’s Laboratories Share Price moves can attract attention quickly.
About Divi’s Laboratories
Divi’s Laboratories operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company is a Large Cap business with a market capitalisation of Rs 2,53,031.38 Cr. Divi’s Laboratories Share Price reflects a business that is followed for its position in pharma manufacturing and its place among listed healthcare names in India. From the data here, the company’s profile is best described through its sector, industry and financial ratios rather than through product claims. For readers searching Divi’s Laboratories Company News or Divi’s Laboratories Latest News, the most relevant confirmed point is that the company remains a major listed healthcare name with premium valuation and strong return metrics.
Track Divi’s Laboratories Share Price on Univest
Use Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Divi’s Laboratories Share Price on Univest for live price updates, market capitalisation, P/E ratio, P/B ratio, ROE, ROCE, EPS, book value, dividend yield and 52-week levels. Univest also helps follow Divi’s Laboratories Share Price Today alongside sector context, peer comparison and stock analysis in one place. For ongoing monitoring, Divi’s Laboratories Share Price remains a useful healthcare benchmark because the numbers combine price action, valuation and company fundamentals.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Divi's Laboratories Share Price fall today?
Ans. Divi's Laboratories Share Price fell 2.04% to Rs 9,282 from the previous close of Rs 9,475. According to latest Univest figures, the market data confirms the decline, while the news item points to a block trade near Rs 9,400.
What is Divi's Laboratories Share Price today?
Ans. Divi's Laboratories Share Price today is Rs 9,282. It opened at Rs 9,475.30, touched a high of Rs 9,503.15 and a low of Rs 9,268.65, showing that the stock traded near the lower end of the range.
How much did Divi's Laboratories Share Price decline?
Ans. Divi's Laboratories Share Price declined by Rs 193, which equals -2.04%. The fall came from Rs 9,475 to Rs 9,282, so the move is meaningful in absolute and percentage terms for a Large Cap stock.
What is Divi's Laboratories market capitalisation?
Ans. Divi's Laboratories market capitalisation is Rs 2,53,031.38 Cr. That makes Divi's Laboratories Share Price part of a Large Cap company with a much larger market value than the industry median and average.
Is Divi's Laboratories Share Price expensive?
Ans. Divi's Laboratories Share Price trades at a P/E of 85.99 and a P/B of 14.24, both above the industry median and average. Those numbers indicate a premium valuation relative to many healthcare peers.
How does Divi's Laboratories compare with sector peers?
Ans. Divi's Laboratories Share Price trades at a higher P/E than Sun Pharma, Zydus, Cipla and Dr. Reddy’s. Its ROE and ROCE are solid, but the valuation sits above the industry centre.
What are the key fundamentals behind Divi's Laboratories Share Price?
Ans. Divi's Laboratories Share Price is backed by EPS of Rs 110.18, book value of Rs 665.36, ROE of 16.19% and ROCE of 21.51%. Dividend yield stands at 0.32%, which is modest.
Should investors track Divi's Laboratories Share Price on Univest?
Ans. Yes, investors can track Divi's Laboratories Share Price on Univest to follow live price moves, valuation ratios, peer comparison and 52-week levels. The platform keeps all core stock metrics in one place for quick review.
